SOLACI Peripheral Registry Hits the 1000-Patient Mark

We are very proud to say that our multicenter, prospective research registry continues to grow by leaps and bounds.

We want to congratulate the 36 centers from the 9 participating countries and invite the entire community to join this research initiative that aims to collect data on the reality of lower limb angioplasty in Latin America, in order to unify criteria, draw conclusions, and develop strategies to improve daily practice for these procedures.

To be part of the SOLACI PERIPHERAL Registry or learn more about it, contact research@solaci.org

It should be noted that SOLACI Peripheral is a research program open to all centers in Latin America that may be willing to actively participate; in this sense, each participant center will have access to registry data in real time. Furthermore, participants will have authorship rights in all Registry publications and will secure the possibility of using Registry data for their own research projects. 

The benefits of participating

  1. Access our own database dedicated to lower limb angioplasty, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present SOLACI Peripheral outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

Your participation is really important to SOLACI and to the entire SOLACI Peripheral Committee. We would be pleased and honored to have you join us in this important initiative.

To take part of SOLACI Peripheral Registry, please email us to: research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...